The Center for Addiction & Disease Risk Exacerbation (CADRE) is a NIH Center of Biomedical Research Excellence (COBRE) led by Peter Monti, Jasjit S. Ahluwalia, Jennifer Tidey & Tyler Wray. The center supports innovative, interdisciplinary research aimed at identifying how SU exacerbates disease through novel approaches, with a particular emphasis on high-risk and underserved populations. CADRE is housed in the Center for Alcohol & Addiction Studies at the Brown University School of Public Health.
Center for Addiction & Disease Risk Exacerbation
CADRE
The COBRE Center for Addiction and Disease Risk Exacerbation (CADRE) focuses on understanding the mechanisms through which substance use (SU) increases the risk for and progression of chronic disease.
CADRE
The COBRE Center for Addiction and Disease Risk Exacerbation (CADRE) focuses on understanding the mechanisms through which substance use (SU) increases the risk for and progression of chronic disease.
Learn more about CADRE
Established in 2019, the Center for Addiction and Disease Risk Exacerbation (CADRE), is a federally funded NIH Center of Biomedical Research Excellence (COBRE).
Meet the dedicated staff at the Center for Addiction & Disease Risk Exacerbation.
Learn more about the CADRE Administrative Core, Clinical Laboratory Core and REACH Core.
Partner with Us
We offer clinical and recruitment services through our Clinical Laboratory Core and REACH Core. Read more about what we can offer you.
The Clinical Laboratory Core (CLC) provides investigators with the tools they need.
The Recruitment, Engagement and Community Health (REACH) Core is a team of recruitment and marketing experts. We offer a paid service to efficiently manage your enrollment goals to ensure they are met on time.
"We're only at the tip of the iceberg with regard to understanding the role of substance use on chronic disease... The early career scientists who will be supported by this funding will be the people who ultimately chip away at that iceberg."
Center Director
Recent news from CADRE
News & Events CADRE is currently accepting applications for Pilot Project Lead. Support of up to $75,000 will be provided. Intent submissions are due by Friday, September 11, 2026.
Read Article
COBRE Opioids and Overdose
COBRE on Opioids and Overdose, Summit on Stigma 8/13/26
The Center for Addiction and Disease Risk Exacerbation (CADRE) is proud to co-sponsor the COBRE on Opioid and Overdose Summit on Stigma on August 13, 2026, in Providence, RI, with virtual attendance also available. This free, interdisciplinary event will bring together researchers, policymakers, healthcare professionals, harm reductionists, and community members to explore the impact of stigma on the opioid crisis and advance collaborative approaches to research and intervention. Registration is required.
Read Article
A pilot study led by researchers at the Center for Addiction and Disease Risk Exacerbation highlights the value of community-based screenings in identifying previously undetected liver health concerns.
Read Article